ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 266 filers reported holding ICU MED INC in Q4 2019. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $368,000 | +21.5% | 1,973 | +4.1% | 0.00% | +50.0% |
| Q3 2019 | $303,000 | -59.9% | 1,895 | -36.7% | 0.00% | -66.7% |
| Q2 2019 | $755,000 | +14.0% | 2,993 | +8.1% | 0.01% | +20.0% |
| Q1 2019 | $662,000 | -36.8% | 2,768 | -39.4% | 0.01% | -50.0% |
| Q4 2018 | $1,048,000 | -4.6% | 4,566 | +17.6% | 0.01% | -9.1% |
| Q3 2018 | $1,098,000 | +3.2% | 3,883 | +7.1% | 0.01% | -26.7% |
| Q2 2018 | $1,064,000 | +160.8% | 3,625 | +124.2% | 0.02% | +150.0% |
| Q1 2018 | $408,000 | -54.0% | 1,617 | -60.6% | 0.01% | -50.0% |
| Q4 2017 | $886,000 | +39.7% | 4,101 | +20.1% | 0.01% | +20.0% |
| Q3 2017 | $634,000 | -1.7% | 3,415 | -8.8% | 0.01% | -9.1% |
| Q2 2017 | $645,000 | +508.5% | 3,743 | +436.2% | 0.01% | +450.0% |
| Q1 2017 | $106,000 | -8.6% | 698 | -11.8% | 0.00% | -33.3% |
| Q4 2016 | $116,000 | +43.2% | 791 | +21.5% | 0.00% | +50.0% |
| Q3 2016 | $81,000 | +15.7% | 651 | +2.5% | 0.00% | 0.0% |
| Q2 2016 | $70,000 | – | 635 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVR Research LP | 22,000 | $4,719,000 | 3.86% |
| NUANCE INVESTMENTS, LLC | 901,483 | $193,359,000 | 3.73% |
| Nitorum Capital, L.P. | 417,241 | $89,494,000 | 3.46% |
| Tamarack Advisers, LP | 73,000 | $15,452,000 | 3.22% |
| PFM Health Sciences, LP | 267,817 | $57,444,000 | 2.02% |
| KIRR MARBACH & CO LLC /IN/ | 22,222 | $4,766,000 | 1.49% |
| PURA VIDA INVESTMENTS, LLC | 174,399 | $37,407,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,584 | $554,000 | 0.88% |
| Findlay Park Partners LLP | 528,825 | $113,428,000 | 0.79% |
| Altium Capital Management LP | 9,321 | $1,999,000 | 0.75% |